DC Chemicals · Product datasheet

QNZ(EVP4593) — Datasheet

CAT. NO. DC7126

Product page and current package options

ParameterValue
Chemical Name6-Amino-4-(4-phenoxyphenylethylamino)quinazoline
CAS No.545380-34-5
Synonyms6-Amino-4-(4-phenoxyphenylethylamino)quinazoline;QNZ (EVP4593);4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine;EVP4593;EVP-4593;QNZ;NF-kappaB Activation Inhibitor;N4-[2-(4-Phenoxyphenyl)ethyl]-4,6-quinazolinediamine;N4-(4-phenoxyphenethyl)quinazoline-4,6-diamine;InSolution™ NF-kappaB Activation Inhibitor;C22H20N4O;EVP 4593;Curator_000005;NF-kB activation inhibitor;6-amino-4-(4-phenoxyphenylethylamino) quinazoline;QNZ(EVP45
FormulaC22H20N4O
M.Wt356.4204
SMILESO(C1C([H])=C([H])C([H])=C([H])C=1[H])C1C([H])=C([H])C(=C([H])C=1[H])C([H])([H])C([H])([H])N([H])C1C2C([H])=C(C([H])=C([H])C=2N=C([H])N=1)N([H])[H]
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

QNZ shows strong inhibitory effects on NF-κB transcriptional activation and TNF-α production with IC50s of 11 and 7 nM, respectively. EVP4593 is a neuroprotective inhibitor of SOC channel.

In Vitro

QNZ (Compound 11q) has a suppressing effect of the NF-κB mediated-inflammatory response. QNZ inhibits edema formation dose-dependently[1]. QNZ (EVP4593) reduces the number of lysosomes/autophagosomes and store-operated channel (SOC) currents in Huntington's disease (HD). Normalization of calcium transport within neurons in response to QNZ is expect to reduce pathology manifestation. A number of lysosomes/autophagosomes are evaluated in HD and WT neurons treated with QNZ using transmission electron microscopy (TEM). Incubation with QNZ reduces the number of lysosomes/autophagosomes in HD GABAergic medium spiny (GABA MS)-like neurons (GMSLNs) by almost two-fold (from 0.41±0.04 to 0.23±0.04; p<0.05), while WT neurons are not affected. This observation is confirmed by examining lysosome content by flow cytometry (FC) analysis. The median fluorescence intensity is reduced by 34±6 % in HD GMSLNs upon QNZ treatment (p<0.05)[2].

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation